PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-02-10

Date Title Company
10-Feb-2026 360 Business Law Launches US Entity, 360 Business Law Inc, to Support Expansion Across the American Market Businesswire
10-Feb-2026 Experic Announces the Appointment of Matthew Mollan, Ph.D. as Chief Executive Officer Businesswire
10-Feb-2026 CinRx Appoints Rez Halse, PhD, as President to Lead Its Portfolio of Clinical-Stage Development Companies and Accelerate Growth Businesswire
10-Feb-2026 ILiAD Biotechnologies Announces $115M Oversubscribed Series B Financing to Advance BPZE1 Pertussis Vaccine Businesswire
10-Feb-2026 IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions Businesswire
10-Feb-2026 Kincell Bio Announces Partnership with RegCell to Advance Treg Cell Therapies into Clinical Trials for Autoimmune Diseases Businesswire
10-Feb-2026 Santa Ana Bio Announces the Appointment of Newman Yeilding as Chief Medical Officer Businesswire
10-Feb-2026 Survey: 99% of Life Sciences Leaders Say Gross to Net Has Become More Complex Model N
10-Feb-2026 Strong clinical data for Breye Therapeutics’ lead oral asset danegaptide presented at Angiogenesis, Exudation and Degeneration 2026 symposium Breye Therapeutics
10-Feb-2026 Pandemics, obesity drugs and cancer care: Cambridge experts tackle the health issues shaping the UK Cambridge Festival
10-Feb-2026 The Oxford-Harrington Rare Disease Centre Advances Discovery of Therapies for Friedreich’s Ataxia (FA) The Oxford-Harrington Rare Disease Centre
10-Feb-2026 AnalytiChem to showcase new product launches and its wide-ranging lab solutions at Analytica 2026 AnalytiChem
10-Feb-2026 MIMETAS and Partners Launch World’s First Microphysiological Systems Industry Alliance MIMETAS
10-Feb-2026 VectorY Therapeutics Announces First Participant Dosed in Phase 1/2 PIONEER-ALS Clinical Trial of VTx-002 in People with Amyotrophic Lateral Sclerosis (ALS) VectorY Therapeutics
10-Feb-2026 Hans Schambye Appointed as Chief Executive Officer of BOOST Pharma BOOST Pharma
10-Feb-2026 Devonian Reports Positive Results in Pulmonary Fibrosis Study Devonian
10-Feb-2026 Biocomposites gains MDR certification for STIMULAN® Rapid Cure and STIMULAN® Kit Biocomposites
10-Feb-2026 Starlab Space and Auxilium Biotechnologies to Advance Life Sciences Research in Microgravity Businesswire
10-Feb-2026 Evommune Announces Positive Top-line Data from Phase 2a Proof-of-Concept Trial of EVO301 in Moderate-to-Severe Atopic Dermatitis Businesswire
10-Feb-2026 Enanta Pharmaceuticals to Present Preclinical Data for EDP-978, its KIT Inhibitor in Development for the Treatment of Type 2 Immune Diseases, at the 2026 AAAAI Annual Meeting Businesswire